Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association
Cardiovascular disease remains the leading cause of death in patients with diabetes.
Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk …
Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk …
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the …
SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher… - Circulation, 2019 - Am Heart Assoc
The recommendations listed in the present guideline are, whenever possible, evidence
based. An initial extensive evidence review, which included literature derived from research …
based. An initial extensive evidence review, which included literature derived from research …
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of …
SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher… - Circulation, 2019 - Am Heart Assoc
The American Heart Association requests that this document be cited as follows: Grundy SM,
Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella …
Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella …
Statin toxicity: mechanistic insights and clinical implications
NC Ward, GF Watts, RH Eckel - Circulation research, 2019 - Am Heart Assoc
There is now overwhelming evidence to support lowering LDL-c (low-density lipoprotein
cholesterol) to reduce cardiovascular morbidity and mortality. Statins are a class of drugs …
cholesterol) to reduce cardiovascular morbidity and mortality. Statins are a class of drugs …
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
Abstract Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase, has proven beneficial preventive effects on cardiovascular events. However …
reductase, has proven beneficial preventive effects on cardiovascular events. However …
Melatonin as an antioxidant: under promises but over delivers
Melatonin is uncommonly effective in reducing oxidative stress under a remarkably large
number of circumstances. It achieves this action via a variety of means: direct detoxification …
number of circumstances. It achieves this action via a variety of means: direct detoxification …
[HTML][HTML] Statin therapy: review of safety and potential side effects
S Ramkumar, A Raghunath… - Acta cardiologica sinica, 2016 - ncbi.nlm.nih.gov
Background Hydroxymethyl glutaryl coenzyme A reductase inhibitors, commonly called
statins, are some of the most commonly prescribed medications worldwide. Evidence …
statins, are some of the most commonly prescribed medications worldwide. Evidence …
Sphingolipids and phospholipids in insulin resistance and related metabolic disorders
PJ Meikle, SA Summers - Nature Reviews Endocrinology, 2017 - nature.com
Obesity, insulin resistance, type 2 diabetes mellitus and cardiovascular disease form a
metabolic disease continuum that has seen a dramatic increase in prevalence in developed …
metabolic disease continuum that has seen a dramatic increase in prevalence in developed …
[HTML][HTML] HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Background Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to
assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3 …
assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3 …
[HTML][HTML] Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM …
H Cederberg, A Stančáková, N Yaluri, S Modi… - Diabetologia, 2015 - Springer
Methods A total of 8,749 non-diabetic participants, aged 45–73 years, were followed up for
5.9 years. New diabetes was diagnosed in 625 men by means of an OGTT, HbA 1c≥ …
5.9 years. New diabetes was diagnosed in 625 men by means of an OGTT, HbA 1c≥ …